Experience

Emulate, Inc.

• Biotechnology Research
• 1 - 100 Employee

• Vice President, Marketing

  • Oct 2020 - Present



Seven Bridges

• United States
• Biotechnology Research
• 1 - 100 Employee

• SVP, Marketing

  • Feb 2020 - Oct 2020

• Vice President, Marketing

  • Oct 2018 - Feb 2020



VERAVAS, Inc.

• United States
• Medical and Diagnostic Laboratories
• 1 - 100 Employee

• Advisor

  • Jul 2018 - Jan 2019



Motus

• United States
• Software Development
• 300 - 400 Employee

• Vice President, Marketing

  • Jan 2015 - Feb 2018

  Acquired by Thoma Bravo 1/2018 Brought in to build a world-class Marketing team that would assist in accelerating revenue growth. In three short years, we positioned Motus as the industry thought leaders leading to an acquisition by Thoma Bravo and merger with Runzheimer. Vice President, Demand Generation (8/2015 - 12/2017) Director, Demand Generation (1/2015 - 8/2015) Acquired by Thoma Bravo 1/2018 Brought in to build a world-class Marketing team that would assist in accelerating revenue growth. In three short years, we positioned Motus as the industry thought leaders leading to an acquisition by Thoma Bravo and merger with Runzheimer. Vice President, Demand Generation (8/2015 - 12/2017) Director, Demand Generation (1/2015 - 8/2015)



Illumina

• United States
• Biotechnology Research
• 700 & Above Employee

• Senior Manager, Marketing Programs

  • Jan 2008 - Feb 2014

  During my 6-year tenure with Illumina, the company grew from $300M to $1.4B, achieved 80% market share, and dropped the cost of the human genome from $100 million per human genome to only $1,000. Illumina was named "The Smartest Company in the World" by MIT Technology Review in 2014. • Contributed to the commercialization strategy for the most successful genetic analysis instruments on the market. • Created a new brand platform and program that achieved a 30% positive shift in… Show more During my 6-year tenure with Illumina, the company grew from $300M to $1.4B, achieved 80% market share, and dropped the cost of the human genome from $100 million per human genome to only $1,000. Illumina was named "The Smartest Company in the World" by MIT Technology Review in 2014. • Contributed to the commercialization strategy for the most successful genetic analysis instruments on the market. • Created a new brand platform and program that achieved a 30% positive shift in market perception in six months. Marketing Programs Manager (1/2008 - 4/2012) Show less During my 6-year tenure with Illumina, the company grew from $300M to $1.4B, achieved 80% market share, and dropped the cost of the human genome from $100 million per human genome to only $1,000. Illumina was named "The Smartest Company in the World" by MIT Technology Review in 2014. • Contributed to the commercialization strategy for the most successful genetic analysis instruments on the market. • Created a new brand platform and program that achieved a 30% positive shift in… Show more During my 6-year tenure with Illumina, the company grew from $300M to $1.4B, achieved 80% market share, and dropped the cost of the human genome from $100 million per human genome to only $1,000. Illumina was named "The Smartest Company in the World" by MIT Technology Review in 2014. • Contributed to the commercialization strategy for the most successful genetic analysis instruments on the market. • Created a new brand platform and program that achieved a 30% positive shift in market perception in six months. Marketing Programs Manager (1/2008 - 4/2012) Show less



BD

• United States
• Medical Equipment Manufacturing
• 700 & Above Employee

• Marketing Programs Manager

  • Dec 2003 - Jan 2008

  Trade Show and Events Specialist II (10/2004 - 11/2005) Marketing Communications Specialist (12/2003 - 10/2004) Trade Show and Events Specialist II (10/2004 - 11/2005) Marketing Communications Specialist (12/2003 - 10/2004)



BIOVIA

• United States
• Software Development
• 100 - 200 Employee

• Marketing Communications Assistant

  • Sep 2001 - Dec 2003